Total Payments
$4,253
2024 Payments
$204.70
Companies
27
Transactions
136
Medicare Patients
626
Medicare Billing
$73,490
Payment Breakdown by Category
Food & Beverage$3,811 (89.6%)
Other$400.00 (9.4%)
Education$41.87 (1.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,811 | 133 | 89.6% |
| Honoraria | $400.00 | 1 | 9.4% |
| Education | $41.87 | 2 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $679.51 | 51 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $405.37 | 13 | $0 (2022) |
| Encore Dermatology Inc. | $400.00 | 1 | $0 (2018) |
| Sun Pharmaceutical Industries Inc. | $316.31 | 5 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $243.71 | 2 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $240.34 | 8 | $0 (2024) |
| LEO Pharma Inc. | $234.00 | 10 | $0 (2021) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $230.62 | 6 | $0 (2018) |
| GENZYME CORPORATION | $190.19 | 5 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $174.81 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $204.70 | 12 | E.R. Squibb & Sons, L.L.C. ($77.81) |
| 2023 | $338.12 | 11 | E.R. Squibb & Sons, L.L.C. ($162.53) |
| 2022 | $283.42 | 14 | GENZYME CORPORATION ($82.22) |
| 2021 | $332.81 | 13 | PFIZER INC. ($126.82) |
| 2020 | $311.83 | 12 | Sun Pharmaceutical Industries Inc. ($143.93) |
| 2019 | $572.19 | 8 | Regeneron Healthcare Solutions, Inc. ($243.71) |
| 2018 | $1,501 | 41 | Encore Dermatology Inc. ($400.00) |
| 2017 | $709.03 | 25 | PFIZER INC. ($187.99) |
All Payment Transactions
136 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.36 | General |
| Category: Immunology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $15.24 | General |
| Category: Immunology | ||||||
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.07 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $13.08 | General |
| Category: Immunology | ||||||
| 07/30/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: DERMATOLOGY | ||||||
| 07/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: DERMATOLOGY | ||||||
| 06/28/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $16.06 | General |
| Category: Immunology | ||||||
| 05/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Immunology | ||||||
| 04/05/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Inflammation | ||||||
| 11/13/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Inflammation | ||||||
| 11/11/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: DERMATOLOGY | ||||||
| 08/25/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $32.77 | General |
| Category: Dermatology | ||||||
| 07/11/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: DERMATOLOGY | ||||||
| 06/26/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: Inflammation | ||||||
| 06/16/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $7.65 | General |
| Category: Immunology | ||||||
| 05/16/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: DERMATOLOGY | ||||||
| 05/08/2023 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Dermatology | ||||||
| 05/03/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $142.45 | General |
| Category: Immunology | ||||||
| 04/24/2023 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $12.43 | General |
| Category: Immunology | ||||||
| 02/27/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO | Food and Beverage | In-kind items and services | $28.11 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO, COMIRNATY | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: DERMATOLOGY | ||||||
| 10/03/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 145 | 209 | $29,955 | $18,017 |
| 2022 | 6 | 158 | 251 | $33,060 | $20,039 |
| 2021 | 6 | 132 | 233 | $27,270 | $17,882 |
| 2020 | 7 | 191 | 289 | $27,870 | $17,552 |
Total Patients
626
Total Services
982
Medicare Billing
$73,490
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 111 | $13,875 | $8,189 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 32 | 39 | $6,045 | $4,175 | 69.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,750 | $3,576 | 53.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 12 | 16 | $2,485 | $1,564 | 62.9% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 14 | 16 | $800.00 | $513.66 | 64.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 145 | $18,125 | $10,703 | 59.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $4,750 | $2,701 | 56.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 21 | $3,255 | $2,163 | 66.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 18 | 21 | $2,940 | $2,072 | 70.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,250 | $1,375 | 61.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 20 | 30 | $1,740 | $1,024 | 58.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 150 | $17,700 | $11,606 | 65.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 18 | $2,665 | $1,907 | 71.6% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 13 | 16 | $2,175 | $1,531 | 70.4% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,250 | $1,398 | 62.1% |
| 17000 | Destruction of skin growth | Office | 2021 | 12 | 14 | $1,400 | $787.28 | 56.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 15 | 20 | $1,080 | $653.00 | 60.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 87 | 163 | $16,300 | $10,084 | 61.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 18 | 20 | $2,600 | $1,842 | 70.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 14 | 14 | $2,100 | $1,269 | 60.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 13 | $1,680 | $1,220 | 72.6% |
| 17000 | Destruction of skin growth | Office | 2020 | 16 | 22 | $2,200 | $1,078 | 49.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 20 | 28 | $1,540 | $1,075 | 69.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 24 | 29 | $1,450 | $983.17 | 67.8% |
About Dr. Michael Borok, MD
Dr. Michael Borok, MD is a Specialist healthcare provider based in Northridge, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457379000.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Borok, MD has received a total of $4,253 in payments from pharmaceutical and medical device companies, with $204.70 received in 2024. These payments were reported across 136 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($3,811).
As a Medicare-enrolled provider, Borok has provided services to 626 Medicare beneficiaries, totaling 982 services with total Medicare billing of $73,490. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Dermatopathology, Procedural Dermatology
- Location Northridge, CA
- Active Since 07/18/2006
- Last Updated 03/07/2023
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1457379000
Products in Payments
- EUCRISA (Drug) $679.51
- COSENTYX (Biological) $405.37
- Impoyz (Drug) $400.00
- DUPIXENT (Biological) $262.97
- Sotyktu (Drug) $240.34
- Winlevi (Drug) $172.38
- PICATO (Drug) $169.58
- ONEXTON (Drug) $130.62
- EPIDUO FORTE (Drug) $129.46
- QBREXZA (Drug) $125.00
- Tremfya (Drug) $125.00
- Erivedge (Biological) $122.92
- LIBTAYO (Biological) $121.83
- ODOMZO (Drug) $120.75
- AMELUZ (Drug) $119.33
- ATOPIC DERMATITIS - DISEASE (Drug) $107.97
- SILIQ (Drug) $100.00
- REMICADE (Biological) $94.37
- Otezla (Drug) $73.62
- VTAMA (Drug) $73.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Northridge
Gholamreza Bonabi, M.d.,, M.D.,
Specialist — Payments: $83,341
Specialist $83,341
Dr. Sawsan Barakat, M.d, M.D
Specialist — Payments: $4,360
Specialist $4,360
Dr. Marc Kerner, Md, MD
Specialist — Payments: $4,144
Specialist $4,144
Shawki Saad, Md, MD
Specialist — Payments: $951.71
Specialist $951.71
Xavier Caro, M.d, M.D
Specialist — Payments: $870.75
Specialist $870.75
Renee Dua, M.d, M.D
Specialist — Payments: $868.20
Specialist $868.20